Qi, Hui
Wang, Jing
Cao, Lixia
Funding for this research was provided by:
Mechanism of TRIM44 regulating the progression and development of multiple myeloma through ZEB1 (2022NYFYFG015)
Article History
Received: 24 September 2024
Accepted: 4 February 2025
First Online: 27 February 2025
Declarations
:
: This study was approved by the Ethics Committee of Affiliated Hospital of Inner Mongolia Medical University. All animal experiments should comply with the Ethics Committee of Affiliated Hospital of Inner Mongolia Medical University that approved the study.
: Informed consent was obtained from all individual participants included in the study.
: The authors declare no competing interests.